Express Scripts (NASDAQ: ESRX) reported Q3 EPS of $1.74, in-line with the analyst estimate of $1.74. Revenue for the quarter came in at $25.41 billion versus the consensus estimate of $25.49 billion.

GUIDANCE:

Express Scripts sees FY2016 EPS of $6.36-$6.42, versus prior guidance of $6.33-$6.43 and the consensus of $6.37.

For earnings history and earnings-related data on Express Scripts (ESRX) click here.